Industry trends

A study published in Nature has confirmed that infections with COVID-19 and influenza can activate dormant cancer cells increasing the risk of cancer recurrence.

Rice University has developed a multi-channel bioelectronic sensor that can accurately detect multiple heavy l pollutants in water.

The first AI-designed gene editor has been published in Nature having edited the human genome. The team plans to open-source the most comprehensive CRISPR system data.

In just five months from proof of concept to gram-scale production the synthetic biology listed company NCT has achieved a breakthrough in synthesis with a purity of 99%.

Columbia University has used CRISPR transposase to precisely inactivate intestinal pathogens significantly improving the survival rate of mice.

Tianjin University has developed engineered probiotics in combination with electronic capsules to achieve integrated diagnosis and treatment of intestinal diseases.

A research team from Jiangnan University has engineered Pichia pastoris to achieve efficient conversion of methanol to farnesene.

A Chinese postdoctoral researcher as the first author the Nobel Prize-winning team utilized AI to design TCRs from scratch and is about to establish a company.

在精准免疫治疗需求日益增长的今天，如何高效、特异性地识别病变细胞，尤其是携带微弱病理信号的癌细胞和病毒感染细胞，成为制约 T 细胞疗法普及的关键瓶颈。细胞表面的 I 类主要组织相容性复合体（MHC-I）通过呈递内源性肽段实现免疫监视。当细胞感染病毒或发生癌变时，MHC-I 会展示疾病相关肽段形成 pMHC-I 复合物，成为 T 细胞受体（TCR）识别的靶标。然而，天然 TCR 对特定 pMHC 复